4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-004720
Options or other derivatives
- General Counsel/Secretary acquired 24,303 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Samuel George A. III · General Counsel/Secretary
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-11 | Grant or award : show line 1 in the form Restricted Stock Units | +24,303 | 24,303 | D |
Loading xslF345X03/ownership.xml…